| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.061 | 0.04 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.084 | 0.04 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.04 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.04 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.09 | 0.04 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.04 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.084 | 0.04 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.04 |